4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-056914
10% owner sold 3,124 shares at $29.06 ($90,783)
From the SEC's structured data for this filing
Trades in this filing
UBS Oncology Impact Fund L.P. · 10% owner
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-16 | Sale : show line 1 in the form | −3,124 | $29.06 | $90,783 | 7,648,268 | D |
| Open-market sales · 3,124 sh · avg $29.06 · $90,783 | ||||||
Loading xslF345X03/doc4.xml…